Andrew T Sheehan - Insider Trading Tracker

Introduction

This page provides a comprehensive analysis of the known insider trading history of Andrew T Sheehan. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

Companies with Reported Insider Positions

The SEC filings indicate Andrew T Sheehan has reported holdings or trades in the following companies:

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Andrew T Sheehan. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CORT / Corcept Therapeutics Incorporated - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CORT / Corcept Therapeutics Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2009-02-06	CORT	SHEEHAN ANDREW T	15,299	0.6870	15,299	0.6870	10,510	339	3.1299	37,374	355.61
2008-03-25	CORT	SHEEHAN ANDREW T	693,118	2.7700	693,118	2.7700	1,919,937

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales CORT / Corcept Therapeutics Incorporated - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CORT / Corcept Therapeutics Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Purchases QNST / QuinStreet, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CORT / Corcept Therapeutics Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales QNST / QuinStreet, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CORT / Corcept Therapeutics Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2024-11-20	QNST	SHEEHAN ANDREW T	10,000	21.5000	10,000	21.5000	215,000	264	14.5100	-69,900	-32.51
2023-11-15	QNST	SHEEHAN ANDREW T	50,000	11.4400	50,000	11.4400	572,000
2019-06-12	QNST	SHEEHAN ANDREW T	7,500	16.1000	7,500	16.1000	120,750
2019-05-16	QNST	SHEEHAN ANDREW T	13,888	15.7400	13,888	15.7400	218,597
2019-05-15	QNST	SHEEHAN ANDREW T	18,386	15.4100	18,386	15.4100	283,328
2019-05-14	QNST	SHEEHAN ANDREW T	81,614	15.2100	81,614	15.2100	1,241,349
2018-08-22	QNST	SHEEHAN ANDREW T	27,538	14.3300	27,538	14.3300	394,620
2018-08-21	QNST	SHEEHAN ANDREW T	72,069	14.4100	72,069	14.4100	1,038,514
2018-06-13	QNST	SHEEHAN ANDREW T	25,458	13.9021	25,458	13.9021	353,920
2018-06-12	QNST	SHEEHAN ANDREW T	78,966	13.9278	78,966	13.9278	1,099,823
2018-06-11	QNST	SHEEHAN ANDREW T	21,034	13.7260	21,034	13.7260	288,713

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Purchases YEXT / Yext, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CORT / Corcept Therapeutics Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2018-03-21	YEXT	SHEEHAN ANDREW T	1,000,000	12.0000	1,000,000	12.0000	12,000,000	170	26.8500	14,850,000	123.75

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales YEXT / Yext, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CORT / Corcept Therapeutics Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2019-10-08	YEXT	SHEEHAN ANDREW T	78,140	15.4377	78,140	15.4377	1,206,302	178	8.8300	-516,325	-42.80

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by Andrew T Sheehan as disclosed to the Securities Exchange Commission (SEC).